Location History:
- Hoffit, IL (2003)
- Hofit, IL (2010 - 2012)
Company Filing History:
Years Active: 2003-2012
Title: The Innovative Contributions of Amnon Michael
Introduction
Amnon Michael, an accomplished inventor based in Hofit, Israel, has made significant strides in the field of biotechnology and vaccine development. With a total of three patents to his name, Michael's work focuses on the adenovirus fiber protein and its applications in creating effective vaccines. His innovations aim to enhance animal immunity against viral infections, showcasing his commitment to public health and scientific advancement.
Latest Patents
Among Michael's latest patents is an invention related to subunits of the adenovirus fiber protein. This innovation includes a nucleic acid sequence encoding a fragment of the adenovirus fiber capsid protein, along with a DNA construct that encompasses a replicable expression vector and at least one heterologous nucleic acid. Furthermore, the patent discusses the recombinant protein that features a segment of the adenovirus fiber capsid protein, specifically the C-terminal knob and part of the shaft domain. This recombinant protein serves as a critical ingredient in vaccinating compositions designed to confer immunity to animals against pathogenic adenoviral infections. Methods for vaccinating domestic birds against such infections are also outlined, demonstrating the practical applications of his research.
Career Highlights
Throughout his career, Amnon Michael has collaborated with prominent companies like Abic Biological Laboratories, Teva Ltd., and Abic Biological Laboratories Ltd. His experience in these reputable institutions has played a vital role in shaping his innovative ideas and ensuring their successful implementation in the field of biotechnology.
Collaborations
In addition to his professional roles, Michael has worked alongside distinguished colleagues such as Jacob Pitcovski and Bezalel Gutter. These collaborations highlight his ability to engage with other experts in the field, fostering an environment of innovation and collective progress.
Conclusion
Amnon Michael continues to be a pivotal figure in the realm of vaccine development and biotechnology. His patents reflect a deep understanding of genetic engineering and its potential to improve animal health. As he pioneers advancements in this crucial field, his contributions are sure to have a lasting impact on future innovations and public health initiatives.